Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (193)

81

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

enthalten in: British journal of cancer | 2013

von Bartlett, J. | Brookes, C. | Piper, T. | +13

82

Baseline tumour measurements predict survival in advanced non-small cell lung cancer

enthalten in: British journal of cancer | 2013

von Gerber, D. | Dahlberg, S. | Sandler, A. | +4

83

Evaluation of prognostic factors in liver-limited metastatic colorectal cancer : a preplanned analysis of the FIRE-1 trial

enthalten in: British journal of cancer | 2013

von Giessen, C. | Fischer von Weikersthal, L. | Laubender, R. | +5

84

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer : a randomised trial by the Norwegian Lung Cancer Study Group

enthalten in: British journal of cancer | 2013

von Strøm, H. | Bremnes, R. | Sundstrøm, S. | +3

85

Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

enthalten in: British journal of cancer | 2013

von Plummer, R. | Lorigan, P. | Brown, E. | +13

86

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase

enthalten in: British journal of cancer | 2013

von Shpilberg, O. | Jackisch, C.

87

MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial

enthalten in: British journal of cancer | 2013

von Hansen, T. | Christensen, R. | Andersen, R. | +3

88

Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer : long-term follow-up

enthalten in: British journal of cancer | 2013

von Creak, A. | Hall, E. | Horwich, A. | +8

89

Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

enthalten in: British journal of cancer | 2013

von Fox, P. | Hudson, M. | Brown, C. | +4

CommentIn: Br J Cancer. 2013 Aug 6;109(3):529. - PMID 23921279

90

Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma

enthalten in: British journal of cancer | 2013

von Sherrill, B. | Wang, J. | Kotapati, S. | +1